Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Molecular & Cellular Proteomics : MCP|January 22, 2010
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progressionJakob Albrethsen, Jaco C Knol, Sander R Piersma, et al.Cellular Oncology (Dordrecht, Netherlands)|January 27, 2012
Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolismBeatriz Carvalho, Anke H Sillars-Hardebol, Cindy Postma, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 2, 2010
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progressionAnke H Sillars-Hardebol, Beatriz Carvalho, Meike de Wit, et al.Journal of Proteomics|January 15, 2014
Colorectal cancer candidate biomarkers identified by tissue secretome proteome profilingMeike de Wit, Huub Kant, Sander R Piersma, et al.Virchows Archiv : an International Journal of Pathology|April 17, 2023
Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancerSuzanna J Schraa, Ellen Stelloo, Miangela M Laclé, et al.Neoplasia (New York, N.Y.)|July 25, 2022
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signatureSanne R Martens-de Kemp, Malgorzata A Komor, Rosa Hegi, et al.Gut|December 31, 2011
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progressionAnke H Sillars-Hardebol, Beatriz Carvalho, Marianne Tijssen, et al.Cellular Oncology (Dordrecht, Netherlands)|June 20, 2012
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progressionAnke H Sillars-Hardebol, Beatriz Carvalho, Jeroen A M Beliën, et al.Gut|September 6, 2011
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progressionMeike de Wit, Connie R Jimenez, Beatriz Carvalho, et al.Annals of Surgical Oncology|June 20, 2012
Lumican and versican are associated with good outcome in stage II and III colon cancerMeike de Wit, Eric J Th Belt, Pien M Delis-van Diemen, et al.Pageof 10